Skip to content
Aperlena

Spain - Immunosuppressants - Environmentally friendly supply of biological medicines with biosimilars for public health centres in the Valencian region

Original España - Inmunosupresores - Suministro respetuoso con el medio ambiente, de medicamentos bilógicos con biosimilares destinado a los centros del ámbito de la sanidad pública valenciana

Awarded Contract award

Key facts

Awarded
Estimated value
€475,534,186
Where
Spain Comunitat Valenciana
Procedure
Open procedure Anyone may submit a bid, in one step, with no pre-selection. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
Original language
Spanish
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 3 weeks ago
Notice number
601081-2026
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Awarded
  2. Published

Summary

Machine-generated summary

The Directorate General for Economic Management, Procurement and Infrastructure of the Regional Ministry of Health in Valencia awarded a contract for the environmentally friendly supply of biological medicines with biosimilars to public health centres in the Valencian health service. The medicines include adalimumab, infliximab, natalizumab, pegfilgrastim, ranibizumab, rituximab, tocilizumab, trastuzumab, ustekinumab, omalizumab, bevacizumab, eculizumab, etanercept, filgrastim and follitropin alfa in various presentations. The contract was awarded on 2026-06-04 to Kern Pharma, S.L., Amgen, S.A., Celltrion Farmaceutica Espana SL, Samsung Bioepis NL BV, Biogen Spain S.L., Accord Healthcare, SLU, Gedeon Richter Iberica SAU, Sandoz Farmaceutica, Orion Pharma S.L. and Fresenius Kabi Espana, S.A. The estimated value is EUR 475,534,185.72.

Description

Suministro respetuoso con el medio ambiente, de medicamentos bilógicos con biosimilares destinado a los centros del ámbito de la sanidad pública valenciana Adalimumab jeringa/pluma precargada 40 mg; Infliximab 120 mg jeringa/pluma precargada; Infliximab 100 mg vial; Natalizumab 300 mg vial; Pegfilgrastim 6mg jeringa precargada; Ranibizumab vial 10mg/ml; Rituximab vial; Tocilizumab vial 20 mg/ml; Tocilizumab jeringa/pluma precargada; Trastuzumab vial; Ustekinumab 45 mg jeringa/pluma precargada; Adalimumab jeringa/pluma precargada 20mg; Ustekinumab 90 mg jeringa/pluma precargada; Ustekinumab 130 mg vial; Omalizumab jeringa precargada 75 mg; Omalizumab jeringa precargada 150 mg; Adalimumab jeringa/pluma precargada 80mg; Bevacizumab vial (25mg/ml); Eculizumab vial 300 mg; Etanercept jeringa/pluma precargada; Filgrastima jeringa; Folitropina alfa jeringa/pluma precargada

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 3 weeks ago

More from this buyer

Full buyer profile

6 open tenders right now

Recent awards

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€11,312,785
9,906 open across Europe right now
Buyer track record on Aperlena
183 notices tracked · 109 awarded
€390,387,773 in awarded contracts

Never miss a tender like this

991 new notices in Medical equipment & pharmaceuticals in Spain in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language